Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01069003 · ClinicalTrials.gov registry record · Phase 4
EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events
A Phase 4 study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,272
- Enrollment target
NCT01069003: Completed Phase 4 study, sponsored by Medtronic Vascular.
NCT01069003 is a Phase 4 study that has completed, run by Medtronic Vascular. The registered enrollment target is 2,272 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (339% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01069003, a Phase 4 study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,272 participants
- Enrollment target
Study Summary
EDUCATE is a prospective, multi-center study designed to collect real-world safety and clinical outcomes in subjects receiving one or more Endeavor Zotarolimus-Eluting Stents and either clopidogrel and aspirin or prasugrel and aspirin as part of a dual antiplatelet therapy (DAPT) drug regimen.
Interventions
- DRUG Placebo Arm
- DRUG Thienopyridine Therapy
- DEVICE Surveillance Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,272 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
What the finished NCT01069003 record still lists
NCT01069003 is an interventional study that assigns participants to a tested intervention. Its 2,272 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (339% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo Arm is the first listed.
NCT01069003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01069003 about?
NCT01069003 is a clinical study titled "EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events". EDUCATE is a prospective, multi-center study designed to collect real-world safety and clinical outcomes in subjects receiving one or more Endeavor Zotarolimus-Eluting Stents and either clopidogrel and aspirin or prasugrel and aspirin as part of a dual antiplatelet therapy (DAPT) drug regimen.
What is the current status of trial NCT01069003?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,272 participants. The study started on 2010-04. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01069003?
The interventions under investigation include: Placebo Arm (DRUG), Thienopyridine Therapy (DRUG), Surveillance Arm (DEVICE).
Who is sponsoring clinical trial NCT01069003?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01069003's enrollment target sits among peer trials
2,272 31st of 2000 higher than 1,970 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia